KEITH VALENTINE
President & CEO
Keith Valentine has over thirty years of executive leadership and commercialization success at high-performing, growth-stage spine and orthopedics companies. He was most recently President and Chief Executive Officer of Orthofix, Inc. following its merger with SeaSpine, Inc. in 2023. Prior to the merger, Mr. Valentine served as President and Chief Executive Officer of SeaSpine, a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders, beginning in 2015.
Prior to joining SeaSpine, Keith served in various leadership capacities at NuVasive, Inc. from 2001-2015, including, most recently, President and Chief Operating Officer. From 1992 through 2000, he held leadership positions with Medtronic Spine & Biologics, most recently as that company’s Vice President of Marketing. He currently serves on various Boards including ATEC Spine, LocateBio as Non-Executive Chair, and at Regentis Biomaterials. Keith earned a B.B.A. from Western Michigan University and studies focused on Pre-Medicine from the University of Michigan.
GREG LAMBRECHT
Founder & Executive Director
Prior to founding Intrinsic in 1999, Greg Lambrecht was a Vice President of Product Development & Marketing at Stryker, a global orthopedic implant company, where he directed the development and launch of numerous successful orthopedic implants. Greg also held various management positions in product and business development within Pfizer’s Medical Technology Group. The core of his career at Pfizer was implementing a process for inventing and developing new technologies that best met the needs of Pfizer’s physician customers worldwide.
Greg received a Bachelor of Science in Nuclear Engineering from the Massachusetts Institute of Technology in 1990 and returned to the same institution for a Masters Degree in Mechanical Engineering in 1993. Greg holds numerous patents in the fields of gynecology, general surgery, cardiology, and orthopedics.
JACOB EINHORN
Chief Technology Officer
Prior to joining Intrinsic in 2000, Jacob Einhorn was Director of Product Development for Nippon Stryker, the Japanese operating division of Stryker Corporation, a global medical device company focused on the orthopedic market, where Jacob was responsible for establishing Stryker’s first R&D presence in Asia.
Jacob received a Bachelor of Arts in Physics and Anthropology from the Johns Hopkins University in 1992. Following several years of consumer products research and consumer advocacy in Washington, DC, he received a Masters of Science in Mechanical Engineering from MIT in 1997. Jacob holds numerous patents in the field of orthopedics and is an active mentor of budding med-tech entrepreneurs.
OSCAR C. YEH
Chief Operating Officer
Oscar Yeh joined Intrinsic in 2004 and was initially responsible for the pre-clinical evaluation of the Barricaid in benchtop, cadaveric, and animal testing. He has held multiple leadership roles within Intrinsic and is currently responsible for research efforts stemming from the clinical and radiographic data collected in the Barricaid randomized clinical trial.
Oscar joined Intrinsic from the University of California, Davis Medical Center where he collaborated on basic science research projects within the Orthopaedic Surgery department. Research efforts included the response of musculoskeletal tissues to mechanical loading through the use of animal models, biomechanical testing, histology, finite element analysis, and constitutive modeling.
Peter Pizzo
Chief Financial Officer
Peter Pizzo joined Intrinsic as its Chief Financial Officer in August 2022. Prior to joining the company, he served as Chief Financial Officer of several private medical device companies, including ControlRad, Inc., Cartiva, Inc., which was sold to Wright Medical for $435 million, and Proxima Therapeutics, Inc., which was sold to Cytyc Corporation for $190 million. From 1996 to 2001, Mr. Pizzo worked for Serologicals Corporation, a publicly traded provider of biological products to life science companies, ultimately serving as Chief Financial Officer. Peter previously served as Vice President and Controller of ValueMark Healthcare Systems, Inc., a privately held owner-operator of psychiatric hospitals and in various senior financial positions at Hallmark Healthcare Corporation, a publicly traded hospital company.
Since 2010, Peter has served on the board of directors of Alimera Sciences, Inc. (Nasdaq: ALIM), a publicly traded global pharmaceutical company, where he chairs the Audit Committee and is a member of the Compensation Committee.
Peter earned his bachelor’s degree in business administration/accounting from Washington and Lee University in Lexington, Virginia.
KELSEY MILLER-TORCHIA
Vice President Clinical Affairs
Kelsey Miller-Torchia joined Intrinsic in 2011 from Impliant, where she served as their Marketing Manager overseeing their US IDE, and clinical trials in Brazil, Israel and Belgium. Kelsey brings with her over 17 years of global clinical trial experience in the spinal industry.
Kelsey started her career in academics with The Boston Spine Group at the renowned New England Baptist Hospital. There she developed and managed their patient registries as well as managed their investigator and IDE clinical trials. Kelsey has a BA in South East Asian Studies and Religion from Tufts University.
RALPH BEENTJES
Vice President, Customer Relations and Sales Operations
Ralph Beentjes joined Intrinsic from MicroPort Orthopedics, where he served as Sr. Director of Operations, with responsibility for Logistics & Customer Service, Global Integrated Business Planning and Product Lifecycle Management. Ralph brings over 13 years of Sales Operations and Customer Relations experience in the medical device industry.
As Vice President of Customer Relations and Sales Operations he manages all aspects of commercialization support, customer targeting and monitoring, utilizing current technology that interfaces with Sales Management and across the business.
Ralph holds a Masters of Science with merit from Tias Nimbas Business School – Bradford University, with a focus on International Business and Marketing.
JAKE TANNER
Vice President, Marketing
Jake Tanner joined Intrinsic following the successful launch of five startup companies related to trauma/burn care, healthcare finance, Ambulatory Surgery Center creation and management, corporate wellness, and internet marketing.
His most recent experience comes from PolyNovo, where as the Director of Marketing he and his team successfully launched a revolutionary trauma and burn care product into a crowded market. While in this role, PolyNovo expanded geographically from 3 to 30+ Sales territories and implemented strategies that resulted in a 15X increase in revenue. He also held Product Management and Marketing positions with ATEC Spine and NuVasive where he developed an excellent track record for all aspects of the positions including the development of marketing strategies, product launches, KOL development and management, training, contracting, etc.
Jake holds a Bachelor of Science with an emphasis on Entrepreneurship from the Marriott School of Business at Brigham Young University.
April Spillane
VP, Health Economics
April Spillane joined Intrinsic in 2022. April has over a decade of experience, with invaluable healthcare industry expertise in reimbursement and the launch of new specialized treatments for Medical Device Companies, Ambulatory Surgery Centers, Value-Based Healthcare Strategies, and knowledge of orthopedics, spine and vascular procedures. She has successfully conceptualized and built out various successful new programs, acting as a one-stop resource leveraging deep knowledge of all aspects of reimbursement related to coding, coverage and payment.
April previously built and led outpatient divisions at SI-BONE and Paradigm Spine, overseeing value-based care initiatives and market entry strategies. She has also consulted with healthcare organizations on post-CPT code launch education and strategy.
Her early work at Implantable Provider Group focused on shifting care sites and aligning reimbursement for innovative procedures. A frequent national speaker on reimbursement, April also founded a Women’s Leadership Council at SI-BONE and mentors women in the industry. She holds a Psychology degree from the University of South Florida.
HEATHER WOZNIAK
National Sales Director, Sales
Heather Wozniak joined Intrinsic in February 2023 from Johnson & Johnson MedTech, where she served as the Director of Sales for Auris Health. In her role, she was responsible for building out the capital and clinical team to launch the Monarch robotic platform.
During her 20+ year career, she’s honed diverse skills in sales, training, marketing and sales leadership. She has a solid track record of building successful teams that bring disruptive technology to the market. Heather holds a Bachelor of Science degree from the University of North Alabama.
CLAYTON KELLUM
National Sales Director, Sales
Clayton Kellum joined Intrinsic in 2023 after serving as Area Sales Director as Acclarent/Johnson & Johnson for the Central US. Before becoming Area Director, Clayton spent time as an ENT Consultant (6 years) and Regional Business Manager (6 years). Acclarent introduced balloon sinuplasty in the Ear, Nose & Throat specialty as an alternative to traditional sinus surgery. They went on to develop other new treatments such as Eustachian Tube Balloon Dilation and 3-D Image Guidance. Before Acclarent, Clayton spent 5 years at Stryker Neuro/Spine/ENT as a sales representative.
Clayton completed undergraduate studies at the University of Mississippi with a degree in Business Administration and resides in Nashville, TN.